MedTrace Logo

Combined Breast Cancer Risk Study

NCT03067389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 553

Last updated 2019-01-15

No results posted yet for this study

Summary

A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk.

Conditions

  • Hereditary Cancer

Interventions

DIAGNOSTIC_TEST

Diagnostic test

Genetic diagnostic test

Sponsors & Collaborators

  • Myriad Genetic Laboratories, Inc.

    lead INDUSTRY

Principal Investigators

  • John Holmsn, MD · Myriad Genetics, Inc.

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-06
Primary Completion
2019-01-08
Completion
2019-01-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067389 on ClinicalTrials.gov